|
|
|
Insider
Information: |
Schuth Alexander O. |
Relationship: |
COFO and Secretary |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
178,066 |
|
Indirect Shares
|
523,749 |
|
|
Direct
Value |
$5,477,310 |
|
|
Indirect Value
|
$16,110,519 |
|
|
Total
Shares |
701,815 |
|
|
Total
Value |
$21,587,829 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
9
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
9
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-9.0
|
Percentage
Gain/Loss : |
0.0%
|
-393.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
COFO and Secretary |
2024-08-21 |
178,066 |
2024-08-21 |
523,749 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-04-13 |
4 |
AS |
$25.04 |
$122,646 |
I/I |
(4,898) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-05-15 |
4 |
AS |
$28.55 |
$286,044 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-05-15 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-07-17 |
4 |
OE |
$5.28 |
$52,800 |
I/I |
10,000 |
538,691 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-07-17 |
4 |
AS |
$29.60 |
$296,000 |
I/I |
(10,000) |
528,691 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-07-18 |
4 |
AS |
$30.01 |
$291,157 |
I/I |
(9,702) |
518,989 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-10 |
4 |
S |
$24.18 |
$68,986 |
I/I |
(2,853) |
521,761 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-14 |
4 |
AS |
$23.67 |
$65,613 |
I/I |
(2,772) |
518,989 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-21 |
4 |
S |
$22.59 |
$55,978 |
I/I |
(2,478) |
521,511 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2023-08-23 |
4 |
AS |
$23.17 |
$58,435 |
I/I |
(2,522) |
518,989 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
53,720 |
170,157 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
539,307 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-02-08 |
4 |
OE |
$0.68 |
$34,000 |
D/D |
50,000 |
210,185 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-02-13 |
4 |
AS |
$17.29 |
$46,960 |
D/D |
(2,716) |
207,469 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-02-14 |
4 |
AS |
$17.66 |
$355,460 |
D/D |
(20,128) |
187,341 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-08-13 |
4 |
S |
$22.89 |
$52,006 |
D/D |
(2,272) |
186,419 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-08-20 |
4 |
AS |
$23.54 |
$137,286 |
D/D |
(5,806) |
180,613 |
0 |
% |
|
DNLI |
Denali Therapeutics Inc. |
COFO and Secretary |
|
2024-08-21 |
4 |
AS |
$24.78 |
$63,115 |
D/D |
(2,547) |
178,066 |
0 |
% |
|
93 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|